Uflex Limited share price
NSE: UFLEX · ISIN INE516A01017
Key numbers
- Market cap
- ₹ 4,796 Cr
- Current price
- ₹ 664.20
- 52-week high / low
- ₹ 724 / 330
- Stock P/E
- 7.0
- Book value
- ₹ 1,123.7
- Dividend yield
- 0.45%
- ROCE
- 6.5%
- ROE
- 4.1%
- Debt to equity
- 1.25
- Sales growth (3 yrs)
- 1.4%
- Profit growth (3 yrs)
- -12.9%
- 1-year return
- 20.9%
About Uflex Limited
Uflex Limited manufactures and sells flexible packaging materials and solutions in Indiaand internationally. It operates through Flexible Packaging Activities, Engineering Activities, and Others segments. The company offers bi-axially oriented polyethylene terephthalate films; bi-axially oriented polypropylene films; cast polypropylene films; metallized films; special effects films; and alox coated films. It also provides primers, water-based flexo and gravure inks, radiation-curable inks, solvent based inks, topcoats, heat seal coatings, barrier coatings for replacements, water-based blister coatings, energy curable and UV coatings, solvent-based matt and gloss coatings, UV LED coatings, and other products, as well as solvent-based, solvent-free and water-based laminating adhesives. In addition, it offers packaging materials, and filling machines. Further, it provides holograms, holographic films, textile value addition products, and holographic metalized papers and board transfers solutions. Additionally, it provides flexible laminates, pre-formed pouches, flexo printed rolls and bags, laminated woven poly propylene bags, electron beam and cast n cure packaging products,…
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 3,838 | 3,745 | 3,526 | 3,955 | 5,201 |
| Operating profit | 457 | 390 | 439 | 585 | 889 |
| Net profit | 58 | 27 | 36 | 196 | 423 |
| EPS (₹) | 8.03 | 3.73 | 5.01 | 27.15 | 58.62 |
Concall summary (2026-08-21)
AI summary of the earnings call transcript · tone: Positive · source document
Guidance & outlook
- Consolidated revenue for Q1 FY27 grew 38% Y-o- Y to Rs.
- Work on our Greenfield Aseptic project in Egypt, 12 billion packs remain on schedule for commissioning in FY27.
Growth & demand
- With 80% incremental revenue contributed by overseas operations and 20% by India, our incremental revenue was RS.
- Total sales volume for the quarter reached 173,471 metric tons, which is 1.7% year-on-year growth.
Margins & costs
- 9,198 million with EBITDA margin expanding 480 basis points Y-o-Y to 17%, marking our highest EBITDA performance in the last 21 quarters.
- 4,410 million incremental EBITDA, reflecting a significant improvement in overseas profitability and driving the consolidated EBITDA growth.
Capex & expansion
- 4,782 million in capex in Q1, primarily allocated across 4 key projects.
- And whatever capex's are remaining, which are new capex's of around, if you put total all this will be around USD 100 million or less USD 80 million capex, we'll be doing going forward.
Balance sheet & cash
- Our Debt-EBITDA margin was around 4.5x, which you would see in this quarter itself, it has come down to 3.5.
- 1x is a big reduction, 30% reduction in our leverage.
Peers in Packaging & Containers
Data for information only, not investment advice. Prices end of day.